M
Marko Pećina
Researcher at University of Zagreb
Publications - 146
Citations - 3225
Marko Pećina is an academic researcher from University of Zagreb. The author has contributed to research in topics: Bone morphogenetic protein & Cartilage. The author has an hindex of 30, co-authored 140 publications receiving 2997 citations.
Papers
More filters
Journal ArticleDOI
Contribution to the etiological explanation of the piriformis syndrome.
TL;DR: The author found that in 6.15% of cases the nervus peroneus communis passes between the tendinous parts of the m.
Journal ArticleDOI
The incidence of injuries in elite junior figure skaters
TL;DR: Programs to improve postural alignment, flexibility, and strength, especially during the asynchronous period of bone and soft tissue development, should be instituted to prevent and reduce overuse syndromes.
Journal ArticleDOI
Influence of the acetabular cup position on hip load during arthroplasty in hip dysplasia
TL;DR: Hip load decreases when the cup is placed more medially or distally and when the femoral neck is longer or lateral offset is used and the charges diminuent au niveau of the hanche.
Journal ArticleDOI
Traumatic and Overuse Injuries Among International Elite Junior Rowers
TL;DR: The types of musculoskeletal problems present in international elite-level junior rowers are defined and whether gender, physical stature, rowing discipline, and training programs affect the incidence of reported injuries is determined.
Journal ArticleDOI
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing
Slobodan Vukicevic,Hermann Oppermann,Donatella Verbanac,Morana Jankolija,Irena Popek,Jasna Curak,Jelena Brkljacic,Martina Pauk,Igor Erjavec,Igor Francetić,Ivo Dumić-Čule,Mislav Jelić,Dragan Durdevic,Tomislav Vlahovic,Ruder Novak,Vera Kufner,Tatjana Bordukalo Nikšić,Marija Kozlovic,Zrinka Banic Tomisic,Jadranka Bubic-Spoljar,Ivancica Bastalic,Smiljka Vikić-Topić,Mihaela Perić,Marko Pećina,Lovorka Grgurevic +24 more
TL;DR: Current issues and challenges with commercial bone devices may be resolved by using novel BMP6 biocompatible device OSTEOGROW, which will be clinically tested in metaphyseal bone fractures, compartments where BMP2 and BMP7 have not been effective.